New Delhi, Feb 3 (PTI): Shares of Divi’s Laboratories surged nearly 6% on Monday after the pharmaceutical company reported an impressive 65% increase in profit after tax (PAT) for the December quarter.
The stock closed 4.75% higher at ₹5,889.30 on the BSE, after hitting an intraday high of ₹5,954.95, marking a 5.91% surge. On the NSE, the stock gained 5.89%, settling at ₹5,949.90 per share.
The remarkable rise in PAT to ₹589 crore in Q3 FY24—up from ₹358 crore in the same quarter last fiscal—was driven by strong sales across markets, the company stated in a regulatory filing.
Additionally, revenue from operations climbed to ₹2,319 crore, compared to ₹1,855 crore in the corresponding period of the previous year, further bolstering investor confidence.
The surge in Divi’s Laboratories' stock reflects strong market optimism surrounding the company's financial performance and growth trajectory.
Last updated by a enewsx:
